Lipophagy and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease progression in an experimental model

Figure 3 Hepatic gene expression of lipophagy markers. A: Sirtuin-1; B: Lysosome-associated membrane protein-2; C: P62/sequestosome-1; D: Transcription factor EB; E: Rubicon; F: Cd36; G: Perilipin 2 (Plin2); H: Plin3; I: Plin5. ^aP < 0.05 considered significant, Mann-Whitney U test. Variables are described as median (25^th-75^th percentiles). Lamp2: Lysosome-associated membrane protein-2; Plin: Perilipin; p62/Sqstm1: P62/sequestosome-1; Sirt1: Sirtuin-1; Tfeb: Transcription factor EB.